PhRMA says reviving Humira antitrust case would create uncertainty for life sciences companies
MLex Summary: The Pharmaceutical Research and Manufacturers of America filed a brief urging the US Court of Appeals for the Seventh Circuit to rule that the existence of two different entry...To view the full article, register now.
Already a subscriber? Click here to view full article